News BenevolentAI to power small molecule drug discovery Deal with MRCT will look for potential new drug targets and candidates.
News Google AI detects breast cancer better than pathologists Algorithm achieves a sensitivity rate of 92%.
Views & Analysis Digital Health Round-up - Siemens and Biogen take on MS imag... A round-up of this week's digital healthcare news. Marco Ricci reports.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.